Brooktree Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Brooktree Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-348	Closed	-$206K	–	38
2022 Q1	$206K	Sell	348 -368	-51%	-$211K	0.13%	38
2021 Q4	$478K	Hold	716	–	–	0.29%	37
2021 Q3	$409K	Sell	716 -321	-31%	-$176K	0.26%	36
2021 Q2	$523K	Hold	1,037	–	–	0.34%	35
2021 Q1	$473K	Hold	1,037	–	–	0.32%	36
2020 Q4	$483K	Hold	1,037	–	–	0.36%	38
2020 Q3	$457K	Hold	1,037	–	–	0.39%	38
2020 Q2	$375K	Sell	1,037 -49	-5%	-$16.4K	0.35%	40
2020 Q1	$308K	Hold	1,086	–	–	0.36%	44
2019 Q4	$353K	Buy	+1,086	New	+$329K	0.32%	47

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brooktree Capital Management's TMO Position: Q2 2022 in Review

Brooktree Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2022, closing a stake of 348 shares — an estimated $206K sold.

Brooktree Capital Management first reported a position in TMO in Q4 2019 and held it in 10 quarters. The position peaked at $523K in Q2 2021. 2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Brooktree Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2022 after selling out during the quarter.
Brooktree Capital Management sold 348 Thermo Fisher Scientific shares in Q2 2022, an estimated $206K.
Brooktree Capital Management first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 10 quarters.
Brooktree Capital Management's Thermo Fisher Scientific position peaked at $523K in Q2 2021.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Brooktree Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.